1. Home
  2. (5E)-BiMatoprost

Contact Angene

Tel: +852 8191 6999

Email: [email protected]

Brc1cnc(nc1)C
Pyrimidine, 5-bromo-2-methyl-
CCCP1(=O)OP(=O)(CCC)OP(=O)(O1)CCC
1,3,5,2,4,6-Trioxatriphosphorinane, 2,4,6-tripropyl-, 2,4,6-trioxide
CC1(C)OB(OC1(C)C)B1OC(C(O1)(C)C)(C)C
2,2'-Bi-1,3,2-dioxaborolane, 4,4,4',4',5,5,5',5'-octamethyl-
O=C(C=Cc1ccccc1)C=Cc1ccccc1.O=C(C=Cc1ccccc1)C=Cc1ccccc1.O=C(C=Cc1ccccc1)C=Cc1ccccc1.[Pd].[Pd]
Tris(dibenzylideneacetone)dipalladium
C1CCC(CC1)P(C1CCCCC1)C1CCCCC1.Cc1cc(C)c(c(c1)C)N1CCN(C1=[Ru](=Cc1ccccc1)(Cl)Cl)c1c(C)cc(cc1C)C
Ruthenium,[1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro(phenylmethylene)(tricyclohexylphosphine)-, (SP-5-41)-

(5E)-BiMatoprost

CCNC(=O)CCC/C=C/C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](CCc1ccccc1)O)O Request for Quotation
Chemical Name: (5E)-BiMatoprost
CAS Number: 1163135-95-2
Product Number: AG008ST0(AGN-PC-0WA29M)
Synonyms:
MDL No:
Molecular Formula: C25H37NO4
Molecular Weight: 415.5656

Identification/Properties

Computed Properties
Molecular Weight:
415.574g/mol
XLogP3:
2.8
Hydrogen Bond Donor Count:
4
Hydrogen Bond Acceptor Count:
4
Rotatable Bond Count:
12
Exact Mass:
415.272g/mol
Monoisotopic Mass:
415.272g/mol
Topological Polar Surface Area:
89.8A^2
Heavy Atom Count:
30
Formal Charge:
0
Complexity:
541
Isotope Atom Count:
0
Defined Atom Stereocenter Count:
5
Undefined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
2
Undefined Bond Stereocenter Count:
0
Covalently-Bonded Unit Count:
1
Compound Is Canonicalized:
Yes

Safety Information

NMR Spectrum

Other Analytical Data

Request for Quotation

Customer Feedback

Chemical Structure


(5E)-Bimatoprost, a type of prostaglandin analog, plays a crucial role in chemical synthesis due to its versatile properties. This compound is commonly utilized in the preparation of various derivatives and analogs for pharmaceutical purposes. In the field of medicinal chemistry, (5E)-Bimatoprost is frequently employed as a key intermediate in the synthesis of prostaglandin-based medications, particularly those used to treat conditions such as glaucoma and eyelash hypotrichosis. Its unique molecular structure and reactivity make it an essential building block for creating novel drug candidates with improved therapeutic profiles. Additionally, the use of (5E)-Bimatoprost in chemical synthesis allows for the exploration of new pathways and strategies for developing advanced pharmaceutical products with enhanced efficacy and reduced side effects.